So a retinal vein occlusion is when there is an occlusion in the blood vessels of the retina that are particularly the veins, and it causes a lack of blood flow, or a lack of perfusion ...

"AlloVir and Kalaris enter merger to advance retinal disease therapies" was originally created and published by ...

Retinal Vein Occlusion Market New report uncovers key trends and growth opportunities in the Retinal Vein Occlusion market, focusing on i ...

The dilemma still holds regarding treatment of the very ischemic central retinal vein occlusion subgroup with ME with profound visual loss. Combination therapy of anti-VEGF agents and a steroid ...

The medication, faricimab, will be offered to patients being treated for advanced retinal vein occlusion (RVO). It is estimated that more than 11,000 people will benefit from the new drug ...

Siloton’s handheld OCT system could soon be used for home-based monitoring of retinal disease, and may one day find its way onto future space missions ...

To date, Vabysmo is approved in more than 100 countries for DME and wet, or neovascular, age-related macular degeneration ...

KOCHI: 68-year-old Thankamma (name changed) from Ernakulam has been a diabetic patient for 15 years. As she did not manage ...

Kalaris is a clinical-stage biopharmaceutical company founded by Samsara BioCapital and focused on development of TH103, a ...

Besides AMD, injections can treat other conditions affecting the light-sensitive retina, such as diabetic retinopathy and retinal vein occlusions (blockages). These injections deliver medication such ...